Please login to the form below

Not currently logged in

Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more

Roche's Perjeta pertuzumabE-cigarettes can save lives - Teva gains approval for EpiPen generic

Armoured CAR ‘could overwhelm solid tumour resistance’

Eureka TherapeuticsEureka Therapeutics and Memorial Sloan Kettering approach shows promise

Regeneron and Teva close gap on rivals with NGF pain drug

regeneron headquartersFasinumab was associated with less pain and improved functional ability compared to placebo

Burson Cohn & Wolfe acquires Hirshorn Zuckerman

Zuckerman and ImperatoAnd CEO Zuckerman will become COO

Pfizer signs mRNA flu vaccine deal with BioNTech

Pharma giant will take on development and commercial responsibility for candidates

Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress

summit therapeuticsNews from pharma, biotech and healthcare

Daily Brief: another departure at Gilead, veteran researcher to head up Karuna

GileadExodus continues from Gilead

Realm toppled by second mid-stage trial flop

RealmThe hypochlorous acid gel failed to show EASI score improvement compared to placebo

The shifting healthcare landscape

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....